OCGN Stock Analysis: Buy, Sell, or Hold?
OCGN - Ocugen, Inc. Common Stock
$1.29
0.05 (4.03%)
▲
5d:
+6.61%
30d:
-5.15%
90d:
-36.76%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 07, 2026
Get Alerted When OCGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OCGN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: OCGN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: OCGN is currently trading at $1.29, which is considered fair relative to its 30-day fair value range of $1.23 to $1.38. From a valuation perspective, the stock is trading at a discount (Forward PE: -5.5) compared to its historical average (40.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OCGN is in a downtrend. Immediate support is located at $1.16, while resistance sits at $1.33. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: OCGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.43 (+785.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OCGN is in a downtrend. Immediate support is located at $1.16, while resistance sits at $1.33. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: OCGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.43 (+785.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.23 -
$1.38
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 785.9% below Wall St target ($11.43)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$1.23 -
$1.38
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.16
Resistance Level
$1.33
Current Trend
Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.49
Wall Street Target
$11.43
(+785.9%)
Revenue Growth (YoY)
3.5%
PE vs Historical
-5.5 vs 40.6
CHEAP
Share & Embed Analysis
Last updated: June 23, 2026 7:30 AM ET
Data refreshes hourly during market hours. Next update: 8:30 AM
Data refreshes hourly during market hours. Next update: 8:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
Advanced OCGN Option Strategies
Professional options setups generated by AI based on today's OCGN price and gamma walls.